477 related articles for article (PubMed ID: 34224817)
1. Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration.
Nakamura T; Oh CK; Zhang X; Lipton SA
Free Radic Biol Med; 2021 Aug; 172():562-577. PubMed ID: 34224817
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
3. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Gu Z; Nakamura T; Lipton SA
Mol Neurobiol; 2010 Jun; 41(2-3):55-72. PubMed ID: 20333559
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2011 Apr; 14(8):1479-92. PubMed ID: 20812868
[TBL] [Abstract][Full Text] [Related]
5. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases.
Nakamura T; Cho DH; Lipton SA
Exp Neurol; 2012 Nov; 238(1):12-21. PubMed ID: 22771760
[TBL] [Abstract][Full Text] [Related]
6. Cell death: protein misfolding and neurodegenerative diseases.
Nakamura T; Lipton SA
Apoptosis; 2009 Apr; 14(4):455-68. PubMed ID: 19130231
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2008 Jan; 10(1):87-101. PubMed ID: 17961071
[TBL] [Abstract][Full Text] [Related]
8. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
[TBL] [Abstract][Full Text] [Related]
9. Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2020 Apr; 32(12):817-833. PubMed ID: 31657228
[No Abstract] [Full Text] [Related]
10. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
Nakamura T; Lipton SA
Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
[TBL] [Abstract][Full Text] [Related]
11. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases.
Nakamura T; Lipton SA
Cell Mol Life Sci; 2007 Jul; 64(13):1609-20. PubMed ID: 17453143
[TBL] [Abstract][Full Text] [Related]
13. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
Nakamura T; Prikhodko OA; Pirie E; Nagar S; Akhtar MW; Oh CK; McKercher SR; Ambasudhan R; Okamoto S; Lipton SA
Neurobiol Dis; 2015 Dec; 84():99-108. PubMed ID: 25796565
[TBL] [Abstract][Full Text] [Related]
14. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
Nakamura T; Lipton SA
Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
[TBL] [Abstract][Full Text] [Related]
15. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
16. Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders.
Nakamura T; Oh CK; Zhang X; Tannenbaum SR; Lipton SA
Antioxid Redox Signal; 2021 Sep; 35(7):531-550. PubMed ID: 33957758
[No Abstract] [Full Text] [Related]
17. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
18. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
[TBL] [Abstract][Full Text] [Related]
19. Protein Quality Control by Molecular Chaperones in Neurodegeneration.
Ciechanover A; Kwon YT
Front Neurosci; 2017; 11():185. PubMed ID: 28428740
[TBL] [Abstract][Full Text] [Related]
20. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
